Old Web
English
Sign In
Acemap
>
authorDetail
>
David O. Riley
David O. Riley
University of Virginia
Medicine
Internal medicine
Oncology
Chemotherapy
high rate
3
Papers
5
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pegaspargase in Practice: Minimizing Toxicity, Maximizing Benefit.
2021
Current Hematologic Malignancy Reports
David O. Riley
Jenna M Schlefman
Hans Christoph Vitzthum Von Eckstaedt
Amy L. Morris
Michael K Keng
Firas El Chaer
Show All
Source
Cite
Save
Citations (0)
Reducing length of stay for patients with acute myeloid leukemia receiving inpatient high-dose cytarabine consolidation chemotherapy.
2021
Journal of Clinical Oncology
Caroline Jones
David O. Riley
Amy Morris
Jeremy Sen
Alana Ferrari
Joshua Humphrey
Jenna VanHoose
Nicholas Schmidt
Jenna Schlefman
Firas El El Chaer
Michael Kenneth Keng
Show All
Source
Cite
Save
Citations (0)
Striving toward Improved Outcomes for Surgically Resectable Non-Small Cell Lung Cancer: the Promise and Challenges of Neoadjuvant Immunotherapy.
2020
Current Oncology Reports
Ryan D. Gentzler
David O. Riley
Linda W. Martin
Show All
Source
Cite
Save
Citations (5)
1